Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 5, 2000, Pages 481-484

  Traore, Hamidou ^a   Fissette, K ^a   Bastian, I ^a   Devleeschouwer, M ^b   Portaels, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Multidrug resistance; Rifampicin; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AFRICA; ANTIBIOTICS, ANTITUBERCULAR; ASIA; DRUG RESISTANCE; EUROPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR PROBE TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SOUTH AMERICA; SPECIES SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034023995     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pablos-Méndez A, Raviglione M C, Laszlo A. et al. Global surveillance for antituberculosis-drug resistance. 1994-1997. World Health Organization/International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998; 338: 1641-1649.
2. Goble M, Iseman M D, Madsen L A, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isonizid and rifampin. N Engl J Med 1993; 328: 527-532.
3. Centers for Disease Control. Nosocomial transmission of multi-drug resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991; 40: 585-591.
4. Tenover F C, Crawford J T, Huebner R E, Geiter L J. Horsburgh C R, Good R C. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993; 31: 767-770.
5. Ramaswamy S. Musser J M. Molecular genetic basis of anti-microbial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle Lung Dis 1998; 79: 3-29.
6. De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 1995; 76: 425-430.
7. Kim B-J, Kim S-Y, Park B-H, et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single strand confirmation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol 1997; 35: 492-494.
8. Watterson S A, Wilson S M, Yates M D, Drobniewski F A. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-1973.
9. Gamboa F, Cardona P J, Manterola J M. et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998; 17: 189-192.
10. Rossau R, Traore H. De Beenhouwer H, et al. Evaluation of the INNO-LiPA-Rif.TB Assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41: 2093-2098.
11. Laszlo A, Rahman M, Raviglione M, Buestro F. WHO/ IUATLD Network of Supranational Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
12. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
13. Lisitsyn N A, Sverdlov E D, Moiseyeva E P, Danilevskaya O N, Nikiforov V G. Mutation to rifampicin resistance at the beginning of the RNA polymerase β subunit gene in Escherichia coli. Mol Gen Genet 1984; 196: 173-174.
14. Yazawa K, Mikami Y, Maeda N, Akao M, Morisaki N. Iwasaki S. Inactivation of rifampicin by Nocardia brasiliensis. Antimicrob Agents Chemother 1993; 37: 1313-1317.
15. Cooksey R C, Morlock G P, Glickman S, Crawford J T. Evaluation of a line probe assay kit for characterisation of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997; 35: 1281-1283.
16. Martilla H J, Soini H, Vyshnevskiy B I, et al. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998; 30: 129-132.
17. Matsiota-Bernard P, Vrioni G. Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-23.
18. Moore M, Onorato I M, McCray E. Castro K G. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997; 278: 833-837.